Michigan Lawmakers Propose Eliminating Co-Pays for Insulin, EpiPens, and Inhalers

State lawmakers in Lansing are taking aim at prescription drug costs with new legislation that could eliminate co-pays for some of the most critical medications. State Senators Darrin Camilleri (D-Trenton) and Chedrick Greene (D-Saginaw) have introduced bills that would require insurers to fully cover insulin, epinephrine (EpiPens), albuterol inhalers, and related medical supplies without any cost-sharing from patients.

The High Cost of Staying Alive

For millions of Americans with diabetes, severe allergies, or asthma, these medications are not optional... they are the difference between life and death. Yet the cost burden continues to grow, forcing many families to make impossible choices between their health and their finances.

"We are trying everything we can to address prescription drug affordability," said Senator Camilleri. "Let's be clear, we need to be covering costs for residents. That's what these bills do, and it makes it easier for them to actually access medicine, which is the most important part of having insurance in the first place."

What the Bills Would Cover

The proposed legislation goes beyond simply capping co-pays. It would require insurers to fully cover:

• Insulin for diabetes management
• Epinephrine auto-injectors (EpiPens) for severe allergic reactions
• Albuterol inhalers for asthma
• Blood glucose monitors and test strips for diabetes monitoring

A Preventative Approach

Senator Greene emphasizes that the effort is preventative, designed to keep people out of already strained hospitals. "We can't do anything if we don't breathe, right?" Greene said. "We can have all the money, we can pass all the legislation we can, but we're struggling to breathe and we're not doing anything. Just simple common sense things that make life easier for some of our most vulnerable people, it's very impactful."

Personal Stakes

For Senator Camilleri, the issue hits close to home. His son carries an EpiPen for severe allergies.

"My son has an EpiPen, and I deal with it myself. He is allergic to a lot of different things. Thankfully, we've not had to use the EpiPen, but they expire," Camilleri explained. "Even if you never used it, you are constantly paying a co-pay in order to have life-saving medicine, and that's something that we know does affect people's budget, and so that's why we're trying to take action today."

Industry Opposition

Insurance industry representatives have previously argued that cost-control efforts can be ineffective and may even drive up costs for other medications. The Michigan Association of Health Plans, which represents insurers in the state, said they are still reviewing the bills.

"The Michigan Association of Health Plans will serve as a resource to the legislature and share information with policymakers on how these measures will impact patients and premiums once we have had time to thoroughly review them," the association said in a statement. They maintain their members "provide access to critical life-saving medications today."

The Road Ahead

The bills have been referred to committee for consideration. However, Senator Camilleri acknowledges that previous drug pricing legislation has faced challenges in the Republican-controlled Michigan House. Speaker Matt Hall (R-Richland Township) told reporters he has yet to see the legislation, so prospects remain uncertain.

For Michigan families struggling with the high cost of essential medications, the proposed legislation represents a potential lifeline... one that could mean the difference between rationing insulin and living a healthy life.

Frequently Asked Questions

Q: What medications would be covered without co-pays under the proposed bills?
A: The legislation would require insurers to fully cover insulin, EpiPens (epinephrine), albuterol inhalers, and diabetes monitoring supplies like blood glucose monitors and test strips.

Q: Who introduced these bills?
A: State Senators Darrin Camilleri (D-Trenton) and Chedrick Greene (D-Saginaw) introduced the legislation to eliminate co-pays for life-saving medications.

Q: What is the status of the bills?
A: The bills have been introduced and referred to committee for consideration. Their prospects in the Republican-controlled House remain uncertain.